Wednesday, August 26, 2015
I Wonder Is This A Co-Incidence Or Is It Just That SA Health E-Health Is Really Problematic?
This appeared a few days ago.
Adelaide | A former head of SA Health says technology that would fix problems with the state’s beleaguered $422 million electronic health system was rejected by the department last year.
Former SA Health CEO Ray Blight told InDaily he had pitched the Miya patient flow system – developed by his SA-based company Alcidion – to SA Health in November last year.
He said the technology was a relatively inexpensive method to speed up doctors’ access to patient information within the Enterprise Patient Administration System (EPAS), as well as other e-health systems.
Doctors have previously reported frustration with the speed of the system, including having to use paper towel to take patient notes, rather than EPAS, because it was too slow to use safely in emergencies.
Miya sends patient test results and other information such as patient allergies in real time from electronic health systems, such as EPAS, to doctor-held iPads.
This avoids the time taken for doctors to actively find results on those systems.
The technology is currently operating in 11 hospitals across the country.
“I’ve put that case to very senior SA Health staff, and the response is – ‘yes, your technology is fantastic, but if we wait long enough, EPAS, in time, will be able to do the same thing’,” said Blight.
A spokesperson for SA Health told InDaily this morning that “the eHealth systems SA Health has invested in will already meet the business need covered by Mr Blight’s proposal”.
However, Blight said, “when I’ve talked to other senior clinicians and shown them our technology, the response has been one of excitement”.
“We win the hearts and minds of the doctors and nurses … because it’s fast, it’s visual, it’s focused on the things that they are worried about: what is this patient’s clinical risk? What are the best options to mitigate that risk?
At the same time we had this released elsewhere:
August 20, 2015 9:12pm Comments
Alcidion Corporation, a leading health informatics company based in Adelaide has entered into a binding agreement with Naracoota Resources Ltd to list Alcidion on the ASX via a Reverse Takeover (Transaction). The Transaction will see Alcidion valued at $12m with a healthy $7.00m in cash post listing.
Adelaide, SA (PRWEB) August 21, 2015
Alcidion Corporation a leading health informatics company based in Adelaide has entered into a binding agreement with Naracoota Resources Ltd to list Alcidion on the ASX via a Reverse Takeover (Transaction). The Transaction will see Alcidion valued at $12m with a healthy $7.00m in cash post listing.
The Transaction is being backed by Allure Capital, the private investment vehicle of technology entrepreneur Mr. Nathan Buzza, BlueSky Private Equity (ASX:BLA) and Patersons Securities Limited. Mr Buzza was previously the second largest shareholder of Clinical Middleware Provider, Azure Healthcare, which catapulted into the spotlight after the stock rocketed from 3.3c to 34c over his two and a half year tenure.
Mr. Buzza commented "I have been privileged to be involved in a number of medical technology companies and without a doubt, Alcidion is the most exciting business I have seen to date. I am extremely excited to be coming on board as an investor with Alcidion. After spending the last two decades in the clinical middleware space, I have had the opportunity to review countless software platforms and the Alcidion platform represents one of the most significant innovations in Clinical Decision Support that I have seen over this time. The entire team at Alcidion should be commended on developing a world class solution and I am looking forward to commercializing the platform."
Lots more here:
A few comments:
First it is good to see we are going to have another health IT stock listed on the ASX - albeit as far as being a revived resources stock one is reminded just how bad things are in the resources sector is at the moment.
Second I rather suspect what Alcidion has is not actually a total solution for the woes in ePAS but is rather a useful and valuable addition to might be able help snatch success from the jaws of failure. One senses the enthusiasm of the proponents!
Third I suspect the SA Health bureaucrats are suffering a pretty big dose of ‘not invented here’ syndrome in rejecting help!
Fourth I suspect it is not a co-incidence the reverse listing and an article in the paper in SA are appearing at the same time.
Good luck to company. I hope the solution can make a real difference and succeed.
Posted by Dr David More MB PhD FACHI at Wednesday, August 26, 2015